Biogen Inc. buy Royal Bank of Canada
Start price
17:45
/
50%
€168.15
Target price
04.10.25
€245.41
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 04.10.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time.Performance without dividends (%)
Name | 1w |
---|---|
Biogen Inc. | - |
iShares Core DAX® | -1.471% |
iShares Nasdaq 100 | -0.486% |
iShares Nikkei 225® | -2.115% |
iShares S&P 500 | 0.394% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $292.00 to $269.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat